Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H15F3O |
Molecular Weight | 280.2849 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(O)(C1=CC=CC=C1)C2=CC(=CC=C2)C(F)(F)F
InChI
InChIKey=DVASNQYQOZHAJN-UHFFFAOYSA-N
InChI=1S/C16H15F3O/c1-2-15(20,12-7-4-3-5-8-12)13-9-6-10-14(11-13)16(17,18)19/h3-11,20H,2H2,1H3
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Cytochromes P450 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2238704 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7918930
600 mg once weekly for 3 weeks.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
2984
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80866560
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
C016914
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
56430-99-0
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107440
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
113755-17-2
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
SUPERSEDED | |||
|
JB0YA8LDOW
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
SUB07694MIG
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
41870
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
100000080685
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
260-176-1
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
4445
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
m5437
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
1196
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY | |||
|
C169987
Created by
admin on Fri Dec 15 15:13:45 GMT 2023 , Edited by admin on Fri Dec 15 15:13:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY